Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berobenatide in Chinese Adults with Overweight or Obesity
NCT07792954Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 3 trial of berobenatide in obesity, sponsored by Pfizer. Started Sep 2026; status: recruiting.
02
Drugs
berobenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07792954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07792954.